ZA201408055B - Compositions and methods for the treatment of local pain - Google Patents
Compositions and methods for the treatment of local painInfo
- Publication number
- ZA201408055B ZA201408055B ZA2014/08055A ZA201408055A ZA201408055B ZA 201408055 B ZA201408055 B ZA 201408055B ZA 2014/08055 A ZA2014/08055 A ZA 2014/08055A ZA 201408055 A ZA201408055 A ZA 201408055A ZA 201408055 B ZA201408055 B ZA 201408055B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- treatment
- methods
- local pain
- pain
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1843CH2012 | 2012-05-10 | ||
| PCT/IB2013/051268 WO2013168006A2 (en) | 2012-05-10 | 2013-02-16 | Compositions and methods for the treatment of local pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201408055B true ZA201408055B (en) | 2016-03-30 |
Family
ID=54193695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/08055A ZA201408055B (en) | 2012-05-10 | 2014-11-04 | Compositions and methods for the treatment of local pain |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2882745A2 (en) |
| JP (1) | JP2016508956A (en) |
| CN (1) | CN105612155A (en) |
| AU (1) | AU2013257727B2 (en) |
| CA (1) | CA2873138A1 (en) |
| SG (1) | SG11201407323WA (en) |
| WO (1) | WO2013168006A2 (en) |
| ZA (1) | ZA201408055B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8361067B2 (en) | 2002-09-30 | 2013-01-29 | Relievant Medsystems, Inc. | Methods of therapeutically heating a vertebral body to treat back pain |
| JP5688022B2 (en) | 2008-09-26 | 2015-03-25 | リリーバント メドシステムズ、インコーポレイテッド | System and method for guiding an instrument through the interior of a bone |
| US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
| WO2013101772A1 (en) | 2011-12-30 | 2013-07-04 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
| US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
| JP6195625B2 (en) | 2012-11-05 | 2017-09-13 | リリーバント メドシステムズ、インコーポレイテッド | System and method for creating a curved pathway through bone and regulating nerves within the bone |
| US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
| WO2018122626A1 (en) * | 2016-12-26 | 2018-07-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
| EP4501263A3 (en) | 2019-09-12 | 2025-03-19 | Relievant Medsystems, Inc. | Systems and methods for tissue modulation |
| WO2022011115A1 (en) | 2020-07-10 | 2022-01-13 | Relievant Medsystems, Inc. | Vertebral denervation in conjunction with vertebral fusion |
| US12082876B1 (en) | 2020-09-28 | 2024-09-10 | Relievant Medsystems, Inc. | Introducer drill |
| JP2024505335A (en) | 2020-12-22 | 2024-02-06 | リリーバント メドシステムズ、インコーポレイテッド | Prediction of spinal neuromodulation candidates |
| US12433668B1 (en) | 2021-11-08 | 2025-10-07 | Relievant Medsystems, Inc. | Impedance stoppage mitigation during radiofrequency tissue ablation procedures |
| GB202305212D0 (en) * | 2023-04-06 | 2023-05-24 | Elixa Mediscience Ltd | Compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302218D0 (en) * | 1993-06-28 | 1993-06-28 | Ab Astra | NEW USE |
| CN1187813A (en) * | 1995-05-01 | 1998-07-15 | 斯科舍集团有限公司 | Fatty acid esters as bioactive compounds |
| GB9704349D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
| AU740914B2 (en) * | 1997-11-19 | 2001-11-15 | Darwin Discovery Limited | Anaesthetic formulation |
| RS20100077A (en) * | 2001-04-30 | 2010-10-31 | Trommsdorff Gmbh. & Co. Kg. Arzneimittel | Pharamceutically active uridine esters |
| US8920843B2 (en) * | 2007-11-07 | 2014-12-30 | Svip5 Llc | Slow release of organic salts of local anesthetics for pain relief |
| US8846068B2 (en) * | 2008-04-18 | 2014-09-30 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising a local anesthetic |
| WO2013024320A1 (en) * | 2011-08-17 | 2013-02-21 | Mahesh Kandula | 2, 6 xylidine derivatives for the treatment of pain |
-
2013
- 2013-02-16 AU AU2013257727A patent/AU2013257727B2/en not_active Ceased
- 2013-02-16 SG SG11201407323WA patent/SG11201407323WA/en unknown
- 2013-02-16 WO PCT/IB2013/051268 patent/WO2013168006A2/en not_active Ceased
- 2013-02-16 JP JP2015510898A patent/JP2016508956A/en active Pending
- 2013-02-16 EP EP13788349.2A patent/EP2882745A2/en not_active Withdrawn
- 2013-02-16 CA CA2873138A patent/CA2873138A1/en not_active Abandoned
- 2013-02-16 CN CN201380030659.5A patent/CN105612155A/en active Pending
-
2014
- 2014-11-04 ZA ZA2014/08055A patent/ZA201408055B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201407323WA (en) | 2014-12-30 |
| AU2013257727A1 (en) | 2014-11-27 |
| AU2013257727B2 (en) | 2016-04-28 |
| EP2882745A2 (en) | 2015-06-17 |
| WO2013168006A2 (en) | 2013-11-14 |
| JP2016508956A (en) | 2016-03-24 |
| CN105612155A (en) | 2016-05-25 |
| WO2013168006A3 (en) | 2016-09-01 |
| CA2873138A1 (en) | 2013-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266582A (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| IL273090B (en) | Methods and compositions for the treatment of cancer | |
| IL261768B (en) | Devices and methods for the treatment of tissue | |
| ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
| EP2675469A4 (en) | Compositions, devices and methods of use thereof for the treatment of cancers | |
| HUE041553T2 (en) | Methods and compositions for the treatment of monogenic diseases | |
| EP2890440A4 (en) | Devices and methods for the treatment of vascular disease | |
| EP2831001A4 (en) | Water treatment compositions and methods of use | |
| GB201320723D0 (en) | Composition and methods of treatment | |
| IL238177A0 (en) | Methods and compositions for the treatment of cancer | |
| EP2958936A4 (en) | Methods and compositions for treatment of forbes-cori disease | |
| ZA201408056B (en) | Compositions and methods for the treatment of mucositis | |
| IL239921A0 (en) | Compositions and methods for treating severe pain | |
| IL239374A0 (en) | Compositions and methods for the treatment of brain cancers | |
| SI2900230T1 (en) | Compounds for the treatment of obesity and methods of use thereof | |
| PL2968478T3 (en) | Compositions and methods for the treatment of carboxyhemoglobinemia | |
| HRP20181761T1 (en) | New alfentanil composition for the treatment of acute pain | |
| ZA201408062B (en) | Compositions and methods for the treatment of multiple sclerosis | |
| ZA201408057B (en) | Compositions and methods for the treatment of moderate to severe pain | |
| ZA201408058B (en) | Compositions and methods for the treatment of epilepsy | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
| ZA201408053B (en) | Compositions and methods for the treatment of metabolic syndrome |